Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

about

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

Item

http://www.wikidata.org/entity/Q42717448

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

@en

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

@nl

type

Item

label

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

@en

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

@nl

prefLabel

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

@en

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

@nl

P1476

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

@en

P2093

John F Gilmer

http://www.w3.org/2001/XMLSchema#string

Paul Matthew O'Byrne

http://www.w3.org/2001/XMLSchema#string

Robert Williams

http://www.w3.org/2001/XMLSchema#string

P2860

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL

Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach

A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.

Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.

The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature.

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.

Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs.

Anti-apoptosis function of TNF-alpha in chronic lymphocytic leukemia: lessons from Crohn's disease and the therapeutic potential of bupropion to lower TNF-alpha.

Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion.

P304

676-694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH7060676

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John Jarlath Walsh

P577

2014-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262786244

http://www.w3.org/2001/XMLSchema#string

P698

24878537

http://www.w3.org/2001/XMLSchema#string

P932

4078515

http://www.w3.org/2001/XMLSchema#string